Biomedical subjects

Francis Moussy

Publications and source records attributed to Francis Moussy.

4 recordsLinked to original sources

PubMed2005

A long-term flexible minimally-invasive implantable glucose biosensor based on an epoxy-enhanced polyurethane membrane.

This paper describes the preparation method as well as the in vitro and in vivo evaluation of a novel flexible glucose biosensor designed for long-term subcutaneous implantation. An epoxy-enhanced polyurethane membrane, which includes ca. 30-40% epoxy resin adhesive and 50-70% polyurethane, has been developed and used for the first time as the outer protective membrane of the sensor. This new membrane was developed to increase the in vivo durability and lifetime of implantable biosensors. This epoxy-polyurethane membrane was shown to be porous and is of excellent durability. A sensor with such a membrane shows excellent long-term stability and can last for 4-8 months in solutions at room temperature. To verify the in vivo performance of the sensor, nine sensors were implanted in three rats and tested regularly. Eight sensors kept functioning well in the rats for 10-56 days. The ninth sensor was damaged during implantation. All original sensitivity data as well as four response curves obtained at days 7, 17, 52 and 56, respectively are presented.

Animals↗

PubMed2005

Coil-type implantable glucose biosensor with excess enzyme loading.

As part of our overall long-term objective of designing a glucose sensor for long-term subcutaneous implantation, a coil-type implantable glucose sensor loaded with excess glucose oxidase (GOD) inside the coils of a 0.125mm diameter coiled platinum-iridium wire has been developed. The excess GOD was immobilized in a glutaraldehyde/bovine serum albumin (BSA) gel reinforced with cotton and located inside the coils chamber of the sensor. The excess GOD increased the lifetime of the sensor. Based on this coil-type design, various coil-type glucose sensors with cellulose acetate (CA), poly(vinyl chloride)(PVC), polyurethane (PU), poly(bisphenol A carbonate) (PC) and Nafion outer membranes were investigated and compared. Comparatively, Nafion based biosensors provided the best long-term response stability. However, Nafion can still not meet the lifetime requirement of the coil-type sensor with high enzyme loading because the observed function failure of these sensors was indeed caused by outer membrane damage rather than loss of enzyme activity. Additional experiments also revealed that hydrogen peroxide accumulation occurred in the GOD impregnated cotton when the sensors were not polarized which could cause a small false positive measurement. However, this artifact can be easily avoided by using an appropriate measurement technique.

Animals↗

PubMed2005

Strategies for testing long-term transcutaneous amperometric glucose sensors.

OBJECTIVES: Transcutaneous and embedded devices were developed for use in characterizing the in vivo performance of subcutaneously implanted glucose sensors. The devices were used as a portal for accessing electrochemical glucose sensors from the exterior. They were designed to prevent the sensors from being pulled out of the animals and the sensor leads from breaking. Development of the devices took into consideration rodent mobility, infection control, and animal welfare balanced with sensor durability, accessibility, and functionality. METHODS: Our approach was developed over five animal protocols spanning a period of 6 months. A total of 68 sensors were implanted with 60 associated devices in 22 Sprague-Dawley outbred rats. RESULTS: The average sensor lifetime was 11.2 +/- 3.1 days with a maximum of 56 days. All-cause sensor failure averaged one sensor per day. As implantation devices were modified, failure attributable to the device was decreased by 40%. The resulting devices showed good durability and allowed for easy sensor access and testing. CONCLUSIONS: These data represent baseline sensor function against which future sensor improvements may be measured. The new devices and techniques described should be a valuable tool in the development of continuous glucose sensors.

Animals↗

PubMed2003

Ex ova chick chorioallantoic membrane as a novel model for evaluation of tissue responses to biomaterials and implants.

One of the major obstacles in developing rationale strategies to control inflammation and fibrosis surrounding implants is the lack of a simple and inexpensive in vivo model to screen tissue reactions to various biomaterials and implants. To begin to fill this gap, we have developed an ex ova model of the chick embryo chorioallantoic membrane (CAM) for testing of tissue reaction to biomaterials and implants. For these studies, we evaluated tissue reactions (inflammation and fibrosis) to two commonly used biomaterials (nylon and silastic) grossly and histologically in the ex ova CAM. Nylon mesh was incorporated within the CAM tissue 4 days postplacement. After 8 days postplacement, the nylon mesh was totally incorporated into the CAM. Histologically, little or no inflammation was seen associated with the incorporated nylon mesh at any time point. In the case of silastic tubing, significant incorporation of the CAM was seen grossly by 1-2 days postplacement. Incorporation of the tubing continued at day 8 postplacement of the silastic tubing, with ingrowth of the CAM into the lumen of the tubing. Histological evaluation of CAMs indicated that no significant tissue reactions (inflammation or fibrosis) occurred in the CAM tissue surrounding the silastic tubing or in the CAM tissue and vasculature that had grown into the silastic tubing. To our knowledge, this report represents the first investigation of the usage of the ex ova CAM model, a shell-less chick embryo model (ex ova), as an in vivo model to test the tissue reactions to biomaterials and implants.

Allantois↗